| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,748 |
1,665 |
$100K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
364 |
357 |
$19K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
519 |
462 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
471 |
456 |
$17K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
382 |
374 |
$9K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
599 |
595 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
57 |
54 |
$5K |
| 92587 |
|
163 |
163 |
$5K |
| 99051 |
|
124 |
121 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
161 |
159 |
$2K |
| 96127 |
|
143 |
143 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
120 |
59 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17 |
17 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
127 |
126 |
$1K |
| 90461 |
|
40 |
40 |
$1K |
| 87081 |
|
71 |
69 |
$472.84 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41 |
41 |
$305.41 |
| 99173 |
|
13 |
13 |
$288.86 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
15 |
15 |
$239.70 |